Skip to main content

Detail

PD OA Dr. Andishe Attarbaschi

Comprehensive Center for Pediatrics
Position: Associate Professor

T +43 1 650 4062570
andishe.attarbaschi@stanna.at

Keywords

Leukemia; Lymphoma

Research interests

I have dedicated my whole 20-years-career as a physician, scientist and "teacher" to pediatric hemato-oncology, especially leukemia and lymphoma.

  • Enhancement of diagnostics and therapy for children with ALL, r/r ALL, NHL, r/r NHL and Hodgkin's disease
  • Outcomes and prognosis in children with ALL, r/r ALL, NHL, r/r NHL and Hodgkin's disease
  • Cancer predisposition
  • Immunotherapy including CAR-T-cell therapies
  • Acute toxicity of cancer therapy
  • Post-transplant lymphoproliferative disease (PTLD)
  • Outreach programs for low- and middle-income countries
  • Cooperation of Cancer Societies (i.e., EICNHL and NHL-i-BFM and SIOPE)

Selected publications

  1. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials. Journal of Clinical Oncology 26(18): 3046-50 (2008)
  2. Non-Hodgkin's lymphoma and pre-existing conditions: spectrum, clinical characteristics and outcome in 222 children and adolescents. Haematologica 101(12): 1581-1591 (2016)
  3. Primary central nervous system lymphoma: initial features, outcome, and late effects in 75 children and adolescents. Blood Advances 3(24): 4291-4297 (2019)
  4. Second malignant neoplasms after treatment of non-Hodgkin’s lymphoma – A retrospective multinational study of 189 children and adolescents. Leukemia (2020)
  5. Rare non-Hodgkin Lymphoma of Childhood and Adolescence: A Consensus Diagnostic and Therapeutic Approach to Pediatric-Type Follicular Lymphoma, Marginal Zone Lymphoma, and Nonanaplastic Peripheral T-cell Lymphoma. Pediatr Blood and Cancer 67(8): e28416 (2020)